Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Morris R |
Modes of action of FK506, cyclosporin A, and rapamycin. |
1994 |
Transplant. Proc. |
pmid:7527964
|
Ericzon BG |
Early graft function in liver transplantation patients. |
1994 |
Transplant. Proc. |
pmid:7527965
|
Shaeffer MS et al. |
Interaction between FK506 and erythromycin. |
1994 |
Ann Pharmacother |
pmid:7513563
|
Ricordi C et al. |
Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts. |
1994 |
Transplant. Proc. |
pmid:7527967
|
Lhöest GJ et al. |
15-Desmethyl FK-506 and 15,31-desmethyl FK-506 from human liver microsomes: isolation, identification (by fast atom bombardment mass spectrometry and NMR), and evaluation of in vitro immunosuppressive activity. |
1994 |
Clin. Chem. |
pmid:7513627
|
Tsugita M et al. |
Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7527969
|
Ueda H et al. |
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. |
1994 |
J. Antibiot. |
pmid:7513682
|
Asselin I et al. |
Polymerase chain reaction-based assay to assess the success of myoblast transplantation in mdx mice. |
1994 |
Transplant. Proc. |
pmid:7527970
|
Tai J et al. |
Effect of FK506 on rat Leydig cell function--in vivo and in vitro study. |
1994 |
Metab. Clin. Exp. |
pmid:7513780
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Egawa H et al. |
FK506 conversion therapy in pediatric liver transplantation. |
1994 |
Transplantation |
pmid:7513911
|
Reggiani P et al. |
Conversion to rescue therapy with FK 506: data from eight liver transplant patients. |
1994 |
Transplant. Proc. |
pmid:7527982
|
Cvetkovic M et al. |
The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. |
1994 |
Transplantation |
pmid:7513912
|
Arakawa H et al. |
Molecular cloning and expression of a novel human gene that is highly homologous to human FK506-binding protein 12kDa (hFKBP-12) and characterization of two alternatively spliced transcripts. |
1994 |
Biochem. Biophys. Res. Commun. |
pmid:7513996
|
Langrehr JM et al. |
Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allografts. |
1994 |
Transpl. Int. |
pmid:7513999
|
Leach KL et al. |
A soluble binding assay for measuring 3H-FK506 binding to the hsp56 immunophilin. |
1994 |
J Immunoassay |
pmid:7530727
|
Genestier L et al. |
Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. |
1994 |
Cell. Immunol. |
pmid:7514101
|
Atcherson MM and Trifillis AL |
Cytotoxic effects of FK506 on human renal proximal tubule cells in culture. |
1994 |
In Vitro Cell. Dev. Biol. Anim. |
pmid:7529625
|
Maruyama K et al. |
FK 506 for vascular permeability factor production in minimal change nephrotic syndrome. |
1994 |
Nephron |
pmid:7517020
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
Peattie DA et al. |
Three distinct messenger RNAs can encode the human immunosuppressant-binding protein FKBP12. |
1994 |
Gene |
pmid:7529739
|
Yoshimura N et al. |
The direct effect of FK506 and rapamycin on interleukin 1(beta) and immunoglobulin production in vitro. |
1994 |
Transplantation |
pmid:7517078
|
Shipston MJ et al. |
Glucocorticoid negative feedback in pituitary corticotropes. Pivotal role for calcineurin inhibition of adenylyl cyclase. |
1994 |
Ann. N. Y. Acad. Sci. |
pmid:7529975
|
Firdaous I et al. |
Pediatric intravenous FK506--how much are we really infusing? |
1994 |
Transplantation |
pmid:7517079
|
Manez R et al. |
Rejection and hepatitis in liver transplants. |
1994 |
Transplantation |
pmid:7517080
|
Dawson VL et al. |
Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. |
1994 |
Neuropharmacology |
pmid:7532825
|
Igarashi T et al. |
Central nervous system toxicity related to FK506 in patients with Behçet's disease. |
1994 |
Ann. Rheum. Dis. |
pmid:7517134
|
Eng WK et al. |
The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth. |
1994 |
Gene |
pmid:7530227
|
Ellis D et al. |
Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. |
1994 |
Pediatr. Nephrol. |
pmid:7517171
|
Klintmalm GB |
FK 506: an update. |
1994 |
Clin Transplant |
pmid:7517226
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Vischi S et al. |
The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518143
|
Okamoto M et al. |
Detection of allograft rejection in rat small bowel transplantation by analysing the in situ distribution of S-phase lymphocytes. |
1994 |
Transplant. Proc. |
pmid:7518145
|
Ippoliti G et al. |
Serum cytokine levels after small bowel transplantation in pigs. |
1994 |
Transplant. Proc. |
pmid:7518146
|
Orita T et al. |
Effect of FK 506 in combination with prednisolone on the graft-vs-host reaction after small bowel transplantation in rats. |
1994 |
Transplant. Proc. |
pmid:7518147
|
Alessiani M et al. |
Total orthotopic small bowel transplantation in swine under FK 506. |
1994 |
Transplant. Proc. |
pmid:7518148
|
Jain A et al. |
FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. |
1994 |
Transplant. Proc. |
pmid:7518149
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Kusne S et al. |
Infectious complications after small bowel transplantation in adults. |
1994 |
Transplant. Proc. |
pmid:7518153
|
Porayko MK et al. |
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. |
1994 |
Mayo Clin. Proc. |
pmid:7508536
|
Martin MF |
Nephrotoxic effects of immunosuppression. |
1994 |
Mayo Clin. Proc. |
pmid:7508537
|
Jindal RM et al. |
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7519799
|
Mor E et al. |
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. |
1994 |
Transplantation |
pmid:7519800
|
Erden E et al. |
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. |
1994 |
Transplantation |
pmid:7519801
|
Dilling MB et al. |
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. |
1994 |
Cancer Res. |
pmid:7508822
|
|
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. |
1994 |
Lancet |
pmid:7520105
|
Yamamoto S et al. |
Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. |
1994 |
J. Invest. Dermatol. |
pmid:7508960
|
Funauchi M et al. |
Effects of an inhibitor for calcium/calmodulin-dependent protein phosphatase, calcineurin, on induction of long-term potentiation in rat visual cortex. |
1994 |
Neurosci. Res. |
pmid:7520143
|
Ito T et al. |
Protective effects of gabexate mesilate on acute pancreatitis induced by tacrolimus (FK-506) in rats in which the pancreas was stimulated by caerulein. |
1994 |
J. Gastroenterol. |
pmid:7520321
|
Zeniya A et al. |
Anti-ulcer effect of FK 506, immunosuppressive agent, in rats. |
1994 |
J. Gastroenterol. |
pmid:7520322
|
Dawson TM et al. |
Nitric oxide: cellular regulation and neuronal injury. |
1994 |
Prog. Brain Res. |
pmid:7533914
|
Connelly PR et al. |
Enthalpy of hydrogen bond formation in a protein-ligand binding reaction. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7510408
|
Surdacka E et al. |
[New immunosuppressive drugs in transplantation]. |
1994 |
Prz. Lek. |
pmid:7532870
|
Shiraga T et al. |
Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. |
1994 |
Biochem. Pharmacol. |
pmid:7510480
|
Hossain M et al. |
Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. |
1994 |
Arerugi |
pmid:7520689
|
Bell A et al. |
Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. |
1994 |
Biochem. Pharmacol. |
pmid:7520696
|
Paslaru L et al. |
GRP78 induction by cyclosporin A in human HeLa cells. |
1994 |
FEBS Lett. |
pmid:7520875
|
Gailliot FP et al. |
Isolation and characterization of the major equilibrium product of FK-520. |
1994 |
J. Antibiot. |
pmid:7520900
|
Stancato LF et al. |
The native v-Raf.hsp90.p50 heterocomplex contains a novel immunophilin of the FK506 binding class. |
1994 |
J. Biol. Chem. |
pmid:7520912
|
Hirano Y et al. |
Mechanism of FK506-induced glucose intolerance in rats. |
1994 |
J Toxicol Sci |
pmid:7520947
|
|
Tacrolimus (FK506) for organ transplants. |
1994 |
Med Lett Drugs Ther |
pmid:7520968
|
Bierer BE |
Biology of cyclosporin A and FK506. |
1994 |
Prog. Clin. Biol. Res. |
pmid:7536944
|
Malyszko J et al. |
FK 506 affects platelet aggregation in vitro. |
1994 |
Thromb. Res. |
pmid:7521072
|
Sharkey J and Butcher SP |
Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. |
1994 |
Nature |
pmid:7522303
|
Bram RJ and Crabtree GR |
Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. |
1994 |
Nature |
pmid:7522304
|
Tanaka A et al. |
Living related liver transplantation across ABO blood groups. |
1994 |
Transplantation |
pmid:7522363
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
Todo S et al. |
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. |
1994 |
Ann. Surg. |
pmid:7522431
|
Ueda K et al. |
Human P-glycoprotein as a multi-drug transporter analyzed by using transepithelial transport system. |
1994 |
Jpn. J. Physiol. |
pmid:7538609
|
Lebeau MC et al. |
Rabbit FKBP-59/HBI does not inhibit calcineurin activity in vitro. |
1994 |
Biochem. Biophys. Res. Commun. |
pmid:7522447
|
Mouzaki A and Rungger D |
Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells. |
1994 |
Blood |
pmid:7522636
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Takahara S et al. |
Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7524219
|
Heitman J et al. |
Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition. |
1994 |
Transplant. Proc. |
pmid:7524220
|
Yoshimura R et al. |
Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat. |
1994 |
Transplant. Proc. |
pmid:7524223
|
Kupferman JC et al. |
Activation of the renal renin-angiotensin system by cyclosporine A and FK 506 in the rat. |
1994 |
Transplant. Proc. |
pmid:7524224
|
Kattner A et al. |
Conversion from CyA to CyA-NOF in a cholestatic liver grafted patient with CyA malabsorption. |
1994 |
Transplant. Proc. |
pmid:7524225
|
Fung JJ and Starzl TE |
FK 506 in solid organ transplantation. |
1994 |
Transplant. Proc. |
pmid:7524226
|
|
Tacrolimus introduced for use in liver transplantation. |
1994 |
Am J Hosp Pharm |
pmid:7524317
|
Lauerma AI et al. |
Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. |
1994 |
Arch. Dermatol. Res. |
pmid:7526805
|
Bush KT et al. |
Induction of the FK506-binding protein, FKBP13, under conditions which misfold proteins in the endoplasmic reticulum. |
1994 |
Biochem. J. |
pmid:7526846
|
Kahan BD |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation. |
1994 |
Ther Immunol |
pmid:7584478
|
Akamine S et al. |
Monitoring canine lung allograft rejection using Ia antigen expression by bronchoalveolar lymphocytes. |
1994 |
Surg. Today |
pmid:7526914
|
Tsuchida M et al. |
The effects of FK506 and dexamethasone on rat thymocyte differentiation. |
1994 |
Ther Immunol |
pmid:7584489
|
Lemoine A et al. |
FK 506 renal toxicity and lack of detectable cytochrome P-450 3A in the liver graft of a patient undergoing liver transplantation. |
1994 |
Hepatology |
pmid:7527003
|
Alnemri ES et al. |
FKBP46, a novel Sf9 insect cell nuclear immunophilin that forms a protein-kinase complex. |
1994 |
J. Biol. Chem. |
pmid:7527037
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Rosenwirth B et al. |
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7527198
|
Griffith BP et al. |
A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. |
1994 |
Transplantation |
pmid:7512292
|
Shaw LM and Brayman KL |
FK-506 therapeutic drug monitoring. |
1994 |
Clin. Chem. |
pmid:7527305
|
Jordan ML et al. |
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. |
1994 |
Transplantation |
pmid:7512293
|
Winkler M et al. |
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. |
1994 |
Clin. Chem. |
pmid:7527306
|
Wijdicks EF et al. |
FK506-induced neurotoxicity in liver transplantation. |
1994 |
Ann. Neurol. |
pmid:7512320
|
Cheng JW et al. |
15N NMR relaxation studies of the FK506 binding protein: dynamic effects of ligand binding and implications for calcineurin recognition. |
1994 |
Biochemistry |
pmid:7512379
|
Mori A et al. |
Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. |
1994 |
Int. Arch. Allergy Immunol. |
pmid:7512393
|
Okubo Y et al. |
Cytokine production in patients with mite-sensitive bronchial asthma. |
1994 |
Int. Arch. Allergy Immunol. |
pmid:7512395
|
Mor E et al. |
Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506. |
1994 |
Transpl. Int. |
pmid:11271340
|
Uemoto S et al. |
Long-term use of FK 506 in living related liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271341
|
Dmitrewski J et al. |
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin? |
1994 |
Transpl. Int. |
pmid:11271342
|